Valuation: Novartis AG

Market Cap 290B 250B 235B 214B 402B 27,747B 408B 2,761B 1,082B 13,878B 1,087B 1,064B 46,225B P/E 2026 *
21.6x
P/E 2027 * 18.5x
Enterprise Value 323B 279B 262B 238B 448B 30,920B 455B 3,076B 1,206B 15,464B 1,212B 1,185B 51,510B EV / Sales 2026 *
5.59x
EV / Sales 2027 * 5.18x
Free-Float
91.66%
Yield 2026 *
2.87%
Yield 2027 * 2.99%
1 day+1.81%
1 week-0.24%
Current month-0.82%
1 month+2.00%
3 months+7.13%
6 months-1.43%
Current year+14.56%
1 week 121.02
Extreme 121.02
125.76
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 67,000 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%-0.24%+25.28%+40.46% 290B
+3.01%+0.22%+74.44%+122.84% 1,055B
+3.34%+4.36%+53.83%+57.18% 632B
+3.07%+3.12%+24.84%+71.77% 442B
+1.35%-2.17%+40.98%+41.50% 351B
+2.13%-0.32%+0.58%+10.77% 243B
+1.48%+2.60%+45.26%+62.35% 227B
+1.35%-3.53%-14.72%-52.63% 200B
+3.06%+5.41%+21.30%+88.61% 172B
+1.36%+2.25%+8.58%-25.75% 153B
Average +2.24%-1.29%+28.04%+41.71% 376.57B
Weighted average by Cap. +2.55%-1.79%+41.87%+64.07%

Financials

2026 *2027 *
Net sales 57.71B 49.84B 46.89B 42.62B 80.16B 5,529B 81.34B 550B 216B 2,765B 217B 212B 9,211B 61.25B 52.9B 49.78B 45.24B 85.09B 5,869B 86.34B 584B 229B 2,935B 230B 225B 9,777B
Net income 13.95B 12.05B 11.34B 10.3B 19.38B 1,337B 19.66B 133B 52.12B 669B 52.38B 51.24B 2,227B 15.5B 13.39B 12.6B 11.45B 21.53B 1,485B 21.85B 148B 57.91B 743B 58.2B 56.94B 2,474B
Net Debt 33.11B 28.6B 26.91B 24.46B 46B 3,173B 46.67B 316B 124B 1,587B 124B 122B 5,286B 27.82B 24.03B 22.61B 20.54B 38.64B 2,665B 39.21B 265B 104B 1,333B 104B 102B 4,440B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
18/08/26 CHF 125.56 +1.75% 1,794,769
17/08/26 CHF 123.40 +0.78% 1,293,936
14/08/26 CHF 122.44 -1.05% 1,619,121
13/08/26 CHF 123.74 -0.37% 1,625,128
12/08/26 CHF 124.20 -1.32% 2,069,949
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
152.36USD
Average target price
154.18USD
Spread / Average Target
+1.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock